• 1
    Westen D, Harnden-Fischer J. Personality profiles in eating disorders: Rethinking the distinction between Axis I and Axis II. Am J Psychiatry 2001; 158: 547562.
  • 2
    Steiger H, Bruce K. Phenotypes, endophenotypes, and genotypes in bulimia spectrum eating disorders. Can J Psychiatry 2007; 52: 220227.
  • 3
    Treasure J, Claudino AM, Zucker N. Eating disorders. Lancet 2010; 375: 583593.
  • 4
    Steiger H, Bruce KR, Groleau P. Neural circuits, neurotransmitters, and behavior: Serotonin and temperament in bulimic syndromes. In: Adan RAH, Kaye WH, editors. Current Topics in Behavioral Neurosciences, Vol. 6. Behavioral Neurobiology of Eating Disorders. Berlin: Springer Berlin Heidelberg, 2011, pp. 125138.
  • 5
    Groleau P, Steiger H, Joober R, Bruce KR, Israel M, Badawi G, et al. Dopamine-system genes, childhood abuse, and clinical manifestations in women with bulimia-spectrum disorders. J Psychiatr Res 2012; 46: 11391145.
  • 6
    Steiger H, Gauvin L, Joober R, Israel M, Badawi G, Groleau P, et al. Interaction of the BcII glucocorticoid receptor polymorphism and childhood abuse in bulimia nervosa (BN): Relationship to BN and to associated trait manifestations. J Psychiatr Res 2012; 46: 152158.
  • 7
    Steiger H, Bruce K, Gauvin L, Groleau P, Joober R, Israel M, et al. Contributions of the glucocorticoid receptor polymorphism (Bcl1) and childhood abuse to risk of bulimia nervosa. Psychiatry Res 2011; 187: 193197.
  • 8
    Brambilla F, Monteleone P. Physical complications and physiological aberrations in eating disorders: A review. In: Maj M, Lopez-Ibor LL, Sartorius N, editors. Eating Disorders. Chichester: Wiley, 2003, pp. 139192.
  • 9
    Bruce KR, Steiger H, Israël M, Groleau P, Ng Ying Kin MNK, Ouellette AS, et al. Cortisol responses on the dexamethasone suppression test among women with bulimia-spectrum eating disorders: Associations with clinical symptoms. Prog neuropsychopharmacol Biolog Psychiatry 2012; 38: 241246.
  • 10
    Turner JD, Muller CP. Structure of the glucocorticoid receptor (NR3C1) gene 5' untranslated region: Identification, and tissue distribution of multiple new human exon 1. J Mol Endocrinol 2005; 35: 283292.
  • 11
    Alt SR, Turner JD, Klok MD, Meijer OC, Lakke EA, Derijk RH, et al. Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed. Psychoneuroendocrinology 2010; 35: 544556.
  • 12
    Breslin MB, Geng CD, Vedeckis WV. Multiple promoters exist in the human GR gene, one of which is activated by glucocorticoids. Mol Endocrinol 2001; 15: 13811395.
  • 13
    Szyf M, Weaver I, Meaney M. Maternal care, the epigenome and phenotypic differences in behavior. Reprod Toxicol 2007; 24: 919.
  • 14
    Turecki G, Ernst C, Jollant F, Labonté B, Mechawar N. The neurodevelopmental origins of suicidal behavior. Trends Neurosci 2010; 35: 1423.
  • 15
    Toyokawa S, Uddin M, Koenen KC, Galea S. How does the social environment ‘get into the mind’? Epigenetics at the intersection of social and psychiatric epidemiology. Soc Sci Med 2012; 74: 6774.
  • 16
    Labonté B, Sudderman M, Maussion G, Navaro L, Yerko V, Mahar I, et al. Genome-wide epigenetic regulation by early-life trauma. Arch Gen Psychiatry 2012; 69: 722731.
  • 17
    Weaver ICG, Meaney MJ, Szyf M. Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proc Natl Acad Sci USA 2006; 103: 34803485.
  • 18
    Labonte B, Yerko V, Gross J, Mechawar N, Meaney MJ, Szyf M,Turecki G. Differential glucocorticoid receptor exon 1B, 1C and 1H expression and methylation in suicide completers with a history of childhood abuse. Biol Psychiatry 2012; 72: 4148; doi:10.1016/j.biopsych.2012.01.034.
  • 19
    McGowan PO, Sasaki A, D'Alessio AC, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009; 12: 342348.
  • 20
    Dammann G, Teschler S, Haag T, Altmüller F, Tuczek F, Dammann R. Increased DNA methylation of neuropsychiatric genes occurs in borderline personality disorder. Epigenetics 2011; 6: 14541462.
  • 21
    Perroud N, Paoloni-Giacobino A, Prada P, Olie E, Salzmann A, Nicastro R, et al. Increased methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of childhood maltreatment: a link with the severity and type of trauma. Transl Psychiatry 2011; 1:e59: 19.
  • 22
    Campbell IC, Mill J, Uher R, Schmidt U. Eating disorders, gene–environment interactions and epigenetics. Neurosci Biobehav Rev 2011; 35: 784793.
  • 23
    Frieling H, Bleich S, Otten J, Römer KD, Kornhuber J, de Zwaan M, et al. Epigenetic downregulation of atrial natriuretic peptide but not vasopressin mRNA expression in females with eating disorders is related to impulsivity. Neuropsychopharmacology 2008; 33: 26052609.
  • 24
    Frieling H, Römer KD, Scholz S,Mittelbach F, Wilhelm J, De Zwaan M, Jacoby GE, Kornhuber J, Hillemacher T, Bleich S. Epigenetic dysregulation of dopaminergic genes in eating disorders. Int J Eat Disord 2010; 43: 577583.
  • 25
    McGowan PO, Meaney MJ, Szyf M. Diet and the epigenetic (re)programming of phenotypic differences in behavior. Brain Res 2008; 1237: 1224.
  • 26
    Ehrlich S, Weiss D, Burghardt R, Infante-Duarte C, Brockhaus S, Muschler M, et al. Promoter specific DNA methylation and gene expression of POMC in acutely underweight and recovered patients with anorexia nervosa. J Psychiatr Res 2010; 44: 827833.
  • 27
    APA. Diagnostic & Statistical Manual of Mental Disorders: DSM-IV-TR, 4th ed. Washington, DC: American Psychiatric Association, 2000.
  • 28
    Fairburn CG, Cooper P. The eating disorders examination. In: Fairburn C, Wilson GT, editors. Binge eating: Nature, assessment and treatment. New York: The Guilford Press, 1993, pp. 317360.
  • 29
    First MB, Spitzer RL, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis-I Disorders, SCID-I/P, Version 2.0, Patient Edition. New York: Biometrics Research Department, New York State Psychiatric Institute, 1996.
  • 30
    Bucholz KK, Robins LN, Shayka JJ, Przybeck TR, Heltzer JE, Goldring E, et al. Performance of two forms of a computer psychiatric screening interview: Version 1 of the DISSI. J Psychiatry Res 1991; 25: 117129.
  • 31
    Blake DD, Weathers FW, Nagy LM,Kaloupek DG, Gusman FD, Charney DS, Keane TM. The development of a clinician-administered PTSD scale. J Trauma Stress 1995; 8: 7590.
  • 32
    Steiger H, Gauvin L, Joober R, Israel M, Ng Ying Kin NMK, Bruce K, et al. Intrafamilial correspondences on platelet [3H-] paroxetine-binding indices in bulimic probands and their unaffected first-degree relatives. Neuropsychopharmacology 2006; 31: 17851792.
  • 33
    First MB, Gibbon M, Spitzer RL. Structured Clinical Interview for DSM-IV Axis-II Personality Disorders, SCID-II, version 2.0. New York: Biometrics Research Department, New York State Psychiatric Institute, 1996.
  • 34
    Fink L, Bernstein DP, Handelsman L, Foote J, Lovejoy M. Initial reliability and validity of the Childhood Trauma Interview. Am J Psychiatry 1995; 152: 13291335.
  • 35
    O'Brien RG, Kaiser MK. MANOVA Method for analyzing repeated measures designs: An extensive primer. Psychol Bull 1985; 97: 316333.
  • 36
    Díaz-Marsá M, Carrasco JL, Basurte E, Pastrana JI, Sáiz-Ruiz J, López-Ibor JJ. Findings with 0.25 mg dexamethasone suppression test in eating disorders: Association with childhood trauma. CNS Spectr 2007; 12: 67580.
  • 37
    Yehuda R, Seckl, J. Minireview: Stress-related psychiatric disorders with low cortisol levels. A metabolic hypothesis. Endocrinology 2006; 152: 44964503.
  • 38
    Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S, et al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol 2012; 13: R43.